C Vulsteke, D Dierickx, E Verbeken, P Wolter, J Thomas, P Schöffski. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Aged, 80 and overAntibodies, Monoclonal/toxicityAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy Protocols/therapeutic useFatal OutcomeHumansImmunotherapy/adverse effectsLung Diseases, Interstitial/chemically inducedLung Diseases, Interstitial/mortalityLymphoma, Large B-Cell, Diffuse/therapyMaleRituximabTime FactorsTreatment Outcome
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedRituximab
Year: 2010 PMID: 20038238 DOI: 10.3109/10428190903518303
Source DB: PubMed Journal: Leuk Lymphoma ISSN: 1026-8022